Form FDA 3674 Certification of Compliance Instructions

INSTRUCTIONS FOR COMPLETION OF FORM FDA 3674 – CERTIFICATION OF COMPLIANCE
Under 42 U.S.C. § 282(j)(5)(B), with Requirements of ClinicalTrials.gov Data Bank (42 U.S.C. § 282(j))
Form 3674 must accompany an application/submission, including certain amendments, supplements, and
resubmissions, submitted under §§ 505, 515, 520(m), or 510(k) of the Federal Food, Drug, and Cosmetic Act
or § 351 of the Public Health Service Act.
1. Name of Sponsor/Applicant/Submitter – This is the name of the sponsor/applicant/submitter of the drug/
biologic/device application/ submission which the certification accompanies. The name must be identical to
that listed on the application/submission.
2. Date – This is the date of the application/submission which the certification accompanies or should have
accompanied, if submitted at a subsequent date.
3. & 4. Provide complete address, telephone number, and fax number of the sponsor/applicant/submitter.
5. Product Information – For Drugs/Biologics: Provide the established, proprietary name, and/or chemical/
biochemical/blood product/ cellular/gene therapy name(s) for the product covered by the application/
submission. Include all available names by which the product is known. For Devices: Provide the common
or usual name, classification, trade or proprietary or model name(s), and/or model number(s). Include all
available names/model numbers by which the product is known. Use a continuation page only if you have filled
in all available spaces.
6. Type of Application/Submission – Identify the type of application/submission which the certification
accompanies by checking the appropriate box. If the name of the type of application/submission is not
identified (i.e. a new IND clinical protocol), check the box labeled “Other.”
7. IND/NDA/ANDA/BLA/PMA/HDE/510(k)/PDP/Other Number – If FDA has previously assigned a number
associated with the application/ submission which this certification accompanies, list that number in this field.
For example, if the application/submission accompanied by this certification is an IND protocol amendment
and the IND number has already been issued by FDA, that number should be provided in this field.
8. Serial Number – In some instances a sequential serial number is assigned to the submission/application. If
there is such a serial number, provide it in this field. If there is no such number, leave this field blank.
9. Certification – This section contains three different check-off boxes.
Box A should be checked if the sponsor/applicant/submitter has concluded that the requirements of 42
U.S.C. § 282(j), section 402(j) of the Public Health Service Act, do not apply because no clinical trials
are included, relied upon, or otherwise referred to, in the application/ submission which the certification
accompanies.
Box B should be checked if the sponsor/applicant/submitter has concluded that the requirements of 42
U.S.C. § 282(j), section 402(j) of the Public Health Service Act, do not apply at the time of submission
of the certification to any clinical trials that are included, relied upon, or otherwise referred to, in the
application/submission which the certification accompanies. This applies to clinical trials that are not
“applicable clinical trials” and to clinical trials included, relied upon, or otherwise referred to in the
application/submission that may be “applicable clinical trials” but that on the date the certification is
signed, 42 U.S.C. § 282(j), section 402(j) of the Public Health Service Act, does not require that any
information be submitted to the ClinicalTrials.gov Data Bank with respect to those clinical trials.
Box C should be checked if the sponsor/applicant/submitter has concluded that the requirements of 42
U.S.C. § 282(j), section 402(j) of the Public Health Service Act, do apply, on the date the certification
is signed, to some or all of the clinical trials that are included, relied upon, or otherwise referred to, in
the application/submission which the certification accompanies. This means that, as of the date the
certification is signed, the requirements of 42 U.S.C. § 282(j), section 402(j) of the Public Health Service
Act, apply to one or more of the clinical trials included, relied upon, or otherwise referred to, in the
application/submission which this certification accompanies.
FORM FDA 3674 SUPPLEMENT (2/13) – FORM INSTRUCTIONS

Page 1 of 2

PSC Publishing Services (301) 443-6740

EF

10. National Clinical Trial (NCT) Numbers – If you have checked Box C in number 9 (Certification), provide
the NCT Number obtained from www.ClinicalTrials.gov for each clinical trial that is an “applicable clinical trial”
and that is included, relied upon, or otherwise referred to, in the application/submission which the certification
accompanies. Type only the number, as the term “NCT” will be added automatically before number. Include
any and all NCT numbers that, as of the date the certification is signed, have been assigned to the clinical
trials included, relied upon, or otherwise referred to, in the application/submission which this certification
accompanies. Multiple NCT numbers may be required for a particular certification, depending on the number
of “applicable clinical trials” included, relied upon, or otherwise referred to, in the application/submission
which the certification accompanies. Leave this field blank if you have checked Box 9.C but, at the time the
certification is completed, you have not yet received any NCT number(s) for the “applicable clinical trial(s)”
included, relied upon, or otherwise referred to in the application/ submission. Use a continuation page only if
you have filled in all available spaces.
11. Name and Title of Person Who Signed in number 11 – Include the name and title of the person who
is signing the certification. If the person signing the certification is not the sponsor/applicant/submitter of the
application/submission, he or she must be an authorized representative of the sponsor/applicant/submitter.
12 & 13. Provide the full address, telephone and fax numbers of the person who is identified in number 11 and
signs the certification in number 15.
14. Provide the date the certification is signed. This date may be different from the date provided in number 2.
15. Signature of Sponsor/Applicant/Submitter or an Authorized Representative – The person signing the
certification must sign in this field.

FORM FDA 3674 SUPPLEMENT (2/13) – FORM INSTRUCTIONS

Page 2 of 2